Investor insights
Sectors invested in
Funding rounds participated in
$10M sweet spot round size
Most of their 18 investments are in rounds between $6.8M and $21M
Investor type
Basic info
Industry
Sectors
Date founded
2001
Investments made
Topas Therapeutics GmbH raised $21M on July 29, 2021
Investors: Gimv, Evotec, Epidarex Capital, BioMedPartners, Vesalius Biocapital and EMBL Ventures
Crescendo Biologics Limited raised $70M on April 30, 2018
Investors: Quan Capital 泉创资本, Takeda UK Limited, Sofinnova Partners, Andera Partners and EMBL Ventures
Arsanis raised $46M on April 26, 2017
Investors: OrbiMed Advisors, Bill & Melinda Gates Foundation, Polaris Partners, SV Life Sciences and EMBL Ventures
Luxendo raised $8.5M on January 12, 2017
Investors: EMBL Enterprise Management Technology Transfer GmbH, LSP (Life Sciences Partners) and EMBL Ventures
Allecra Therapeutics raised $25M on June 15, 2016
Investors: Delos Capital, Edmond de Rothschild, Forbion, Andera Partners and EMBL Ventures
Topas Therapeutics GmbH raised $16M on March 22, 2016
Investors: Gimv, Epidarex Capital and EMBL Ventures
Luxendo raised $6.8M on October 14, 2015
Investors: EQT Life Sciences and EMBL Ventures
ViraTherapeutics GmbH raised $4M on June 24, 2015
Investors: EMBL Ventures
ImevaX GmbH raised $9.6M on October 28, 2014
Investors: BioMedPartners, Wellington Partners and EMBL Ventures
Crescendo Biologics Limited raised $3.3M on April 3, 2014
Investors: Astellas Venture Capital L.L.C., Sofinnova Partners, Imperial College London and EMBL Ventures